Thymanax (agomelatine)
- Region
- 🇪🇺 EU
- Active substance
- agomelatine
- Company
- Les Laboratoires Servier
- Status
- Refused
- Therapeutic area
- Depressive Disorder, Major
- CHMP opinion
- Thu 27 Jul 2006
- Application
- EMEA/H/C/000657
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Valdoxan Authorised · Les Laboratoires Servier
- 🇪🇺 Thymanax Withdrawn · Servier (Ireland) Industries Ltd
- 🇪🇺 Valdoxan Refused · Les Laboratoires Servier
Follow Thymanax
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.